What sector does Amneal Pharmaceuticals, Inc (AMRX) operate in?
Amneal Pharmaceuticals, Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Amneal Pharmaceuticals, Inc (AMRX) current stock price?
As of the latest data, Amneal Pharmaceuticals, Inc stock price is $14.52, with a previous close of $14.77. Amneal Pharmaceuticals, Inc lost -$0.25 in the last trading session, representing a -1.69% loss.
What is Amneal Pharmaceuticals, Inc (AMRX) current market capitalization?
Amneal Pharmaceuticals, Inc market cap is approximately 4.56 billion.
What is Amneal Pharmaceuticals, Inc (AMRX) Earnings Per Share (EPS)?
The trailing EPS is $0.01, and the forward EPS is $0.94.
What is Amneal Pharmaceuticals, Inc (AMRX) Price-to-Earnings (P/E) ratio?
Amneal Pharmaceuticals, Inc current P/E ratio is 1,452, with a forward P/E of 15.5.
What is Amneal Pharmaceuticals, Inc (AMRX) EBITDA?
Amneal Pharmaceuticals, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 111.66 million.
Does Amneal Pharmaceuticals, Inc (AMRX) pay dividends?
No. Amneal Pharmaceuticals, Inc does not pay a dividend.
How did Amneal Pharmaceuticals, Inc (AMRX) perform in its most recent earnings report?
In the last report (September 30, 2025), Amneal Pharmaceuticals, Inc posted an EPS surprise of 21.43% and a revenue surprise of 1.38%.
When is Amneal Pharmaceuticals, Inc (AMRX) next earnings report?
Amneal Pharmaceuticals, Inc is expected to release its next earnings report on December 31, 2025.
What is Amneal Pharmaceuticals, Inc (AMRX) beta (volatility) score?
Amneal Pharmaceuticals, Inc has a beta of 1.347, suggesting it is more volatile than the market.